Alpha Dna Investment Management LLC Castle Biosciences Inc Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 16,763 shares of CSTL stock, worth $471,375. This represents 0.18% of its overall portfolio holdings.
Number of Shares
16,763
Previous 20,038
16.34%
Holding current value
$471,375
Previous $436,000
9.63%
% of portfolio
0.18%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding CSTL
# of Institutions
203Shares Held
26.2MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$85.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$51.3 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$49.2 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$40.4 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$35.5 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $739M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...